Prostate cancer is the second commonest cancer in men, 1 in 8 men will be diagnosed with prostate cancer during their lifetime, accounting for 9% of all cancer deaths among men in Europe. The socio-economic burden associated with PCa is predicted to dramatically increase in the coming years due to our ageing population. Studies have reported a prevalence of 59% by the age of 79 years.
PIONEER’s unique approach is to firstly identify critical evidence gaps in prostate cancer care through a detailed prioritisation exercise including all stakeholders (i.e. clinicians, patients, researchers, industry etc.). PIONEER will then standardise and integrate existing ‘big data’ from high quality and multidisciplinary data sources from prostate cancer patients across different stages of the disease into a single innovative data platform. Based on a unique set of methodologies and advanced analytical methods, PIONEER will attempt to transform the field of prostate cancer care with particular focus on improving prostate cancer-related outcomes, health system efficiency and the quality of health and social care delivered to all prostate cancer patients and their families. In addition, PIONEER will aim to provide standardised care pathways for all clinical centres across Europe.

https://prostate-pioneer.eu/

Partners

  • Astellas Pharma
  • Bayer
  • Cancer Intelligence Limited
  • Covance
  • European Alliance for Personalised Medicine
  • European Association of Urology
  • European Cancer Patient Coalition
  • European Institute for Systems Biology and Medicine
  • European Organisation for Research and Treatment of Cancer
  • Erasmus Universitair Medisch Centrum Rotterdam
  • Fraunhofer IZI
  • Goeteborgs Universitet
  • Imperial College of Science Technology and Medicine
  • International Consortium for Health Outcomes Measurement
  • Janssen Pharmaceutical
  • King’s College London
  • Lund University
  • Orion Corporation
  • Pinsent Masons LLP
  • Radboud University Medical Center
  • Sanofi
  • SAS Institute
  • Swedish Institute for Health Economics
  • Technische Universität Dresden
  • The Hyve B.V
  • The University Court of the University of Aberdeen
  • Ttopstart
  • Universitaetsklinikum Hamburg-Eppendorf
  • University of Tampere
  • Universita Vita-Salute San Raffaele
  • Varian Medical Systems
  • Weizmann Institute of Science